Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
Top Cited Papers
- 5 July 2000
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (14) , 8104-8109
- https://doi.org/10.1073/pnas.97.14.8104
Abstract
The classical dopamine hypothesis of schizophrenia postulates a hyperactivity of dopaminergic transmission at the D 2 receptor. We measured in vivo occupancy of striatal D 2 receptors by dopamine in 18 untreated patients with schizophrenia and 18 matched controls, by comparing D 2 receptor availability before and during pharmacologically induced acute dopamine depletion. Acute depletion of intrasynaptic dopamine resulted in a larger increase in D 2 receptor availability in patients with schizophrenia (19% ± 11%) compared with control subjects (9% ± 7%, P = 0.003). The increased occupancy of D 2 receptors by dopamine occurred both in first-episode neuroleptic-naive patients and in previously treated chronic patients experiencing an episode of illness exacerbation. In addition, elevated synaptic dopamine was predictive of good treatment response of positive symptoms to antipsychotic drugs. This finding provides direct evidence of increased stimulation of D 2 receptors by dopamine in schizophrenia, consistent with increased phasic activity of dopaminergic neurons.Keywords
This publication has 56 references indexed in Scilit:
- Presynaptic dopaminergic function in the striatum of schizophrenic patientsSchizophrenia Research, 1997
- Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brainJournal of Chemical Neuroanatomy, 1995
- Cortical regulation of subcortical dopamine systems and its possible relevance to schizophreniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: Implications for positron emission tomography of the human brainSynapse, 1989
- In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): A potential imaging ligand for D-2 dopamine receptors in spectLife Sciences, 1988
- Alphamethylparatyrosine and Tetrabenazine in Movement DisordersClinical Neuropharmacology, 1982
- Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in ratsNature, 1980
- Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptorsLife Sciences, 1977
- Metabolism of α-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesisJournal of Clinical Investigation, 1968